https://www.thebodypro.com/author/canadian-aids-treatment-information-exchange

Latest by Canadian AIDS Treatment Information Exchange

On-Demand PEP to Prevent HIV Infection Img

On-Demand PEP to Prevent HIV Infection

Doctors in Toronto did something novel: They prescribed post-exposure prophylaxis (PEP) in advance so that in case of potential exposure patients can initiate PEP on their own and then subsequently seek medical attention.

Will De-Simplification of HIV Treatment Become Common in High-Income Countries? Img

Will De-Simplification of HIV Treatment Become Common in High-Income Countries?

As more people start HIV treatment, researchers are exploring ways to cut costs. Single tablets can be replaced by a few pills comprising cheaper generic drugs.

Pregnancy and Infant Feeding: Can We Say U=U About the Risk of Passing HIV to an Infant? Img

Pregnancy and Infant Feeding: Can We Say U=U About the Risk of Passing HIV to an Infant?

An examination of what we know about the risk of passing HIV through pregnancy, childbirth, and infant feeding.

Who Tends to Gain Weight With HIV Treatment? Img
News

Who Tends to Gain Weight With HIV Treatment?

Researchers found that people taking common combinations of HIV drugs had increases in weight and body mass index, and those who were relatively thin or older prior to starting therapy were most likely to gain weight.

PrEP's Social Impact on the Lives of Some Gay Men in Toronto Img
Men Who Have Sex With Men

PrEP's Social Impact on the Lives of Some Gay Men in Toronto

Researchers found that a large proportion of men felt the need to conceal their use of PrEP from friends, family and sexual partners because of attitudes toward PrEP use.

Pitavastatin Found to Reduce Levels of Bad Cholesterol and Inflammation Img
Cardiovascular

Pitavastatin Found to Reduce Levels of Bad Cholesterol and Inflammation

A one-year clinical trial has found that this potent statin can help to normalize cholesterol levels in HIV-positive people.

Canakinumab in HIV Reduces Inflammation Img

Canakinumab in HIV Reduces Inflammation

Researchers tested a single injection of the antibody canakinumab in HIV-positive people taking antiretroviral therapy and found that the drug significantly reduced inflammation and did not cause harm, at least in the short term.

Inflammation in Arteries vs. Lymph Nodes Img

Inflammation in Arteries vs. Lymph Nodes

Researchers found that inflammation in the arteries of HIV-positive people was "modestly increased" and that the level of inflammation in the lymph nodes was generally higher than in the arteries.

suPAR -- An Early Warning Signal for Chronic Inflammation Img

suPAR -- An Early Warning Signal for Chronic Inflammation

Researchers have found that having an elevated level of a protein that is released into the blood of people during chronic inflammation was linked to an increased risk for subsequent serious health problems as well as diminished survival.

Exploring HIV and Inflammation Img

Exploring HIV and Inflammation

Chronic HIV infection is associated with relatively high levels of inflammation and a growing body of evidence suggests that inflammation may increase the risk for a range of health problems.